Effect of adenosine receptor subtypes stimulation on mixed lymphocyte reaction

European Journal of Pharmacology

Volumn 564, Issue 1-3, 2007, Pages 204-210

  Takahashi, Hideo Kohka ^a   Iwagaki, Hiromi ^a   Hamano, Ryosuke ^a   Kanke, Toru ^a   Liu, Keyue ^a   Sadamori, Hiroshi ^a   Yagi, Takahito ^a   Yoshino, Tadashi ^a   Sendo, Toshiaki ^a   Tanaka, Noriaki ^a   Nishibori, Masahiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Adenosine; Interleukin 18; Monocyte

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLORO N CYCLOPENTYLADENOSINE; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5 PHENYLACETYLAMINO 1,2,4 TRIAZOLO[1,5 C]QUINAZOLINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; FLAVINE MONONUCLEOTIDE; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 18; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; UNCLASSIFIED DRUG;

ARTICLE; CELL INTERACTION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADENOSINE; CELL PROLIFERATION; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; INHIBITORY CONCENTRATION 50; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-18; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTES; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A3; VASODILATOR AGENTS;

EID: 34250652110     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.02.005     Document Type: Article

References (30)

1. Affleck D.G., Bull D.A., Albanil A., Shao Y., Brady J., Karwande S.V., Eichwald E.J., and Shelby J. Interleukin-18 production following murine cardiac transplantation: correlation with histologic rejection and the induction of INF-γ. J. Interferon Cytokine Res. 21 (2001) 1-9
2. 2A receptor agonist (CGS) on ischemia/reperfusion injury in isolated rat liver. Apoptosis 10 (2005) 955-962
3. 2A adenosine receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells. J. Leukoc. Biol. 72 (2002) 1027-1036
4. 1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines. Blood 103 (2004) 3117-3121
5. 2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am. J. Physiol.: Gasterointest. Liver Physiol. 286 (2004) G285-G293
6. i. J. Biol. Chem. 266 (1991) 17778-17783
7. Fujimori Y., Takatsuka H., Takemoto Y., Hara H., Okamura H., Nakanishi K., and Kakishita E. Elevated interleukin (IL)-18 levels during acute graft-versus-host disease after allogeneic bone marrow transplantation. Br. J. Haematol. 109 (2000) 652-657
8. Isobe M., Yagita H., Okumura K., and Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 255 (1992) 1125-1127
9. Jacobson K.A., van Galen P.J.M., and Williams M. Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J. Med. Chem. 35 (1992) 407-422
10. Katsuno G., Takahashi H.K., Iwagaki H., Mizuno K., Yagi T., Mori S., Saito S., Yoshino T., Nishibori M., and Tanaka N. The immunosuppressive effects of ciprofloxacin during human mixed lymphocyte reaction. Clin. Immunol. 119 (2006) 110-119
11. Kist-van Holthe J.E., Gasser M., Womer K., Najafian N., Dong V., Samsonov D.V., Geehan C.S., Chandraker A., Sayegh M.H., and Waaga A.M. Regulatory functions of alloreactive Th2 clones in human renal transplant recipients. Kidney Int. 62 (2002) 627-631
12. 2 cells and exerts its effect independently of IL-12. J. Immunol. 158 (1997) 1541-1550
13. Le Moine A., Goldman M., and Abramowicz D. Multiple pathways to allograft rejection. Transplantation 73 (2002) 1373-1781
14. Macedo C., Popescu I., Abu-Elmagd K., Reyes J., Shapiro R., Zeevi A., Berghaus J.M., Wang L.F., Lu L., Thomson A.W., Storkus W.J., Fung J.J., and Metes D. Augmentation of type-1 polarizing ability of monocyte-derived dendritic cells from chronically immunosuppressed organ-transplant recipients. Transplantation 79 (2005) 451-459
15. Morichika T., Takahashi H.K., Iwagaki H., Yagi T., Saito S., Kubo S., Yoshino T., Akagi T., Mori S., Nishibori M., and Tanaka N. Effect of prostaglandin E2 on intercellular adhesion molecule-1 and B7 expression in mixed lymphocyte reaction. Transplantation 75 (2003) 2100-2105
16. Net M., Valero R., Almenara R., Barros P., Capdevila L., Lopez-Boado M.A., Ruiz A., Sanchez-Crivaro F., Miquel R., Deulofeu R., Taura P., Manyalich M., and Garcia-Valdecasas J.C. The effect of normothermic recirculation is mediated by ischemic preconditioning in NHBD liver transplantation. Am. J. Transplant. 5 (2005) 2385-2392
17. 1 response mediates both acute and chronic rejection. Transpl. Immunol. 14 (2005) 21-25
18. Ohshima Y., and Delespesse G. T cell derived IL-4 and dendritic cell-derived IL-12 regulate the lymphokine-producing phenotype of alloantigen-primed naïve human CD4 T cells. J. Immunol. 158 (1997) 629-636
19. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., and Hattori K. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378 (1995) 88-91
20. Panther E., Idzko M., Herouy Y., Rheinen H., Gebicke-Haerter P.J., Mrowietz U., Dichmann S., and Norgauer J. Expression and function of adenosine receptors in human dendritic cells. FASEB J. 15 (2001) 1963-1970
21. 2A receptors in ischemia. Ann. N.Y. Acad. Sci. 939 (2001) 74-84
22. Poulsen S.A., and Quinn R. Adenosine receptors: new opportunities for future drugs. Bioorg. Med. Chem. 6 (1998) 619-641
23. Reddy P., Teshima T., Kukuruga M., Ordemann R., Liu C., Lowler K., and Ferrara J.L. Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis. J. Exp. Med. 194 (2001) 1433-1440
24. Shaiegan M., Iravani M., Babaee G.R., and Ghavamzadeh A. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients. Transpl. Immunol. 15 (2006) 223-227
25. Striz I., Krasna E., Honsova E., Lacha J., Petrickova K., Jaresova M., Lodererova A., Bohmova R., Valhova S., Slavcev A., and Vitko S. Interleukin-18 (IL-18) upregulation in acute rejection of kidney allograft. Immunol. Lett. 99 (2005) 30-35
26. Takahashi H.K., Iwagaki H., Tamura R., Yagi T., Yoshino T., Mori S., Tanaka N., and Nishibori M. Effect of antibodies against intercellular adhesion molecule-1, B7, and CD40 on interleukin-18-treated human mixed lymphocyte reaction J. Pharmacol. Sci. 97 (2005) 447-450
27. Takahashi, H.K., Iwagaki, H., Hamano, R., Wake, H., Kanke, T., Liu, K., Yoshino, T., Tanaka, N., Nishibori, M., in press. Effects of adenosine on adhesion molecule expression and cytokine production in human PBMC depend on the receptor subtype activated. Br. J. Pharmacol.
28. Tamura R., Takahashi H.K., Iwagaki H., Yagi T., Mori S., Yoshino T., Nishibori M., and Tanaka N. Effect of beta2-adrenergic receptor agonists on intercellular adhesion molecule (ICAM)-1, B7, and CD40 expression in mixed lymphocyte reaction. Transplantation 77 (2004) 293-301
29. Van Belle H., Goossens F., and Wynants J. Formation and release of purine catabolites during hypoperfusion, anoxia, and ischemia. Am. J. Physiol. 1252 (1987) H886-H893
30. Zhu S.N., Yamada J., Streilein J.W., and Dana M.R. ICAM-1 deficiency suppresses host allosensitization and rejection of MHC-disparate corneal transplants. Transplantation 69 (2000) 1008-1013